Continuum Advisory’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Sell |
13,806
-622
| -4% | -$115K | 0.31% | 79 |
|
|
2025
Q1 | $3.02M | Buy |
14,428
+23
| +0.2% | +$4.82K | 0.39% | 59 |
|
|
2024
Q4 | $2.56M | Buy |
14,405
+96
| +0.7% | +$17.1K | 0.33% | 77 |
|
|
2024
Q3 | $2.43M | Buy |
14,309
+604
| +4% | +$102K | 0.31% | 80 |
|
|
2024
Q2 | $2.35M | Sell |
13,705
-32
| -0.2% | -$5.49K | 0.34% | 73 |
|
|
2024
Q1 | $2.2M | Buy |
13,737
+5,107
| +59% | +$819K | 0.33% | 76 |
|
|
2023
Q4 | $1.34M | Sell |
8,630
-3,163
| -27% | -$490K | 0.19% | 137 |
|
|
2023
Q3 | $1.76M | Sell |
11,793
-24
| -0.2% | -$3.58K | 0.28% | 95 |
|
|
2023
Q2 | $1.59M | Sell |
11,817
-193
| -2% | -$26K | 0.25% | 106 |
|
|
2023
Q1 | $1.91M | Buy |
12,010
+1,106
| +10% | +$176K | 0.32% | 84 |
|
|
2022
Q4 | $1.76M | Buy |
10,904
+132
| +1% | +$21.3K | 0.32% | 87 |
|
|
2022
Q3 | $1.45M | Buy |
10,772
+453
| +4% | +$60.8K | 0.26% | 104 |
|
|
2022
Q2 | $1.58M | Sell |
10,319
-123
| -1% | -$18.8K | 0.29% | 100 |
|
|
2022
Q1 | $1.53M | Buy |
10,442
+751
| +8% | +$110K | 0.29% | 93 |
|
|
2021
Q4 | $1.31M | Buy |
9,691
+102
| +1% | +$13.8K | 0.3% | 84 |
|
|
2021
Q3 | $1.03M | Sell |
9,589
-611
| -6% | -$65.9K | 0.28% | 92 |
|
|
2021
Q2 | $1.15M | Buy |
10,200
+473
| +5% | +$53.3K | 0.36% | 71 |
|
|
2021
Q1 | $1.04M | Buy |
9,727
+354
| +4% | +$37.8K | 0.43% | 65 |
|
|
2020
Q4 | $1M | Sell |
9,373
-198
| -2% | -$21.2K | 0.46% | 62 |
|
|
2020
Q3 | $834K | Buy |
9,571
+5,388
| +129% | +$470K | 0.46% | 64 |
|
|
2020
Q2 | $415K | Buy |
4,183
+560
| +15% | +$55.6K | 0.26% | 84 |
|
|
2020
Q1 | $266K | Buy |
+3,623
| New | +$266K | 0.18% | 109 |
|